Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01
Tizanidine Tablet
Product Images NDC 71335-0424
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-0424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02
A line graph showing plasma Tizanidine concentration (ng/ml) over time (hours) from dosing. It compares four groups: 4 mg Tizanidine tablets with food, 4 mg tablets without food, 4 mg capsules with food, and 4 mg capsules without food, with concentration peaks occurring between 1 and 3 hours post-dose and declining thereafter up to 24 hours.*
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03
A line graph showing improvement in Ashworth Score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. Lines indicate greater improvement with higher tizanidine doses compared to placebo, with error bars representing variability.*
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04
A line chart comparing the improvement in Ashworth Score over study weeks between tizanidine (mean dose 28.8 mg) and placebo. The x-axis marks End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis shows score improvement ranging from -6 to 2. Data points with error bars indicate greater improvement for tizanidine than placebo at all time points.*
Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05
Label Image (Lbl713350424)
Tizanidine 2 mg oral tablet packaging label by Bryant Ranch Prepack. The label shows the product name and strength prominently with a comparison to Zanaflex 2 mg tablet by Apotex Inc. It includes storage instructions to keep at room temperature 20-25°C (68-77°F) and a caution about possible dizziness or drowsiness. The label displays a lot number, expiration placeholder, and barcode with NDC 7133504241.*
Lbl713350914
Tizanidine 4 mg oral tablet label from Bryant Ranch Prepack, packaged in Burbank, CA. The label references comparison to Zanaflex 4 mg tablets by Unichem Laboratories. It displays storage instructions at room temperature 20°-25°C (68°-77°F) and a warning about possible dizziness or drowsiness. Includes lot number and an NDC barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
